نتایج جستجو برای: recurrent breast cancer

تعداد نتایج: 1093634  

Journal: :razavi international journal of medicine 0
mohamad amin pourhoseingholi gastroenterology and liver diseases research center, shahid beheshti university of medical sciences, tehran, ir iran; gastroenterology and liver diseases research center, shahid beheshti university of medical sciences, tehran, ir iran. tel: +98-2122432515, fax: +98-2122432517 mohsen vahedi department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, ir iran asma pourhoseingholi gastroenterology and liver diseases research center, shahid beheshti university of medical sciences, tehran, ir iran sara ashtari gastroenterology and liver diseases research center, shahid beheshti university of medical sciences, tehran, ir iran

background breast cancer (bc) is the most common cancer in iranian women. studying the mortality statistics is important to monitor the effects of screening programs or the influence of earlier diagnosis on the burden of this chronic disease. misclassification is still a problem in the iranian death registry data and about 20% of death statistics are recorded in misclassified categories. object...

2013
Jalal Vahedian Ali Zare Mehrjardi Ehsan Saraee Amir Saraee

Idiopathic granulomatous mastitis (IGM) is an uncommon chronic inflammatory lesion of the breast, which is sometimes misdiagnosed as breast cancer or breast abscess. We present a 30-year old woman who came to our clinic with a recurrent and multiple abscesses in her left breast. After twice incision and drainage of the abscess, and after pathologic diagnosis of IGM, she was treated with prednis...

Journal: :Endocrine-related cancer 2008
Danielle Meijer Anieta M Sieuwerts Maxime P Look Ton van Agthoven John A Foekens Lambert C J Dorssers

Tamoxifen treatment of estrogen-dependent breast cancer ultimately loses its effectiveness due to the development of resistance. From a functional screen for identifying genes responsible for tamoxifen resistance in human ZR-75-1 breast cancer cells, fibroblast growth factor (FGF) 17 was recovered. The aim of this exploratory study was to assess the predictive value of FGF17 and the receptors F...

2016
Qixing Tan Qinghong Qin Weiping Yang Bin Lian Qinguo Mo Changyuan Wei

Recurrent breast cancer remains an incurable malignancy and cannot be removed by surgery in the majority of cases. This study aimed to explore the feasibility and efficacy of the combination of I brachytherapy and chemotherapy for the treatment of unresectable recurrent breast cancer. Patients with unresectable recurrent breast cancer treated between January 2011 and December 2014 with a combin...

Journal: :archives of razi institute 2016
f. abedini m. moharrami p. shams m. eslampanah h. adeldost

despite a lot of research, the etiology and progression of breast cancer remain incompletely understood. recently, human cytomegalovirus (hcmv) was reported as a risk factor for breast cancer. the aim of this study was to know whether breast cancer could be caused by cytomegalovirus or not? in this experiment seventeen samples of razi/a mice with spontaneous breast cancer were being gathered fr...

2018
Ava Kwong John C.W. Ho Vivian Y. Shin Allison W. Kurian Edmund Tai Laura J. Esserman Jeffery N. Weitzel Po-Han Lin Michael Field Susan M. Domchek Jessica Lo Hextan Y.S. Ngan Edmond S.K. Ma Tsun L. Chan James M. Ford

BRCA1/2 mutations are significant risk factors for hereditary breast and ovarian cancer (HBOC), its mutation frequency in HBOC of Chinese ethnicity is around 9%, in which nearly half are recurrent mutations. In Hong Kong and China, genetic testing and counseling are not as common as in the West. To reduce the barrier of testing, a multiplex SNaPshot genotyping panel that targeted 25 Chinese BRC...

Journal: :iranian journal of pathology 2008
nasrin shayanfar behrang kazeminejad

background and objective: determination of hormone receptor status in the management of breast cancer is well-established. the aim of this study was to evaluate the frequency of androgen receptor (ar) expression in invasive ductal carcinoma of breast. materials and methods: for this purpose, 55 cases of invasive ductal breast carcinoma were examined using a monoclonal antibody against ar on for...

Journal: :archives of breast cancer 0
david krag department of surgical oncology, university of vermont, vermont, usa

na

Journal: :archives of breast cancer 0
elise bo-gallon psychology and psychopathology clinic, department of psycho-oncology, sainte catherine institute, avignon, france

na

Journal: :archives of breast cancer 0
mojgan karbakhsh department of community and preventive medicine, tehran university of medical sciences, tehran, iran

na

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید